4E Therapeutics
Austin
About 4E Therapeutics
4E Therapeutics is developing an innovative therapy for chronic neuropathic pain and is also at the forefront of discovering and developing compounds to treat migraine and acute pain. Neuropathic pain is a serious unmet medical need. They make an effort to regulate the activity of pain-sensing neurons in the peripheral nervous system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.2M
- Last round: Grant (Nov 2021)
- Website: 4etherapeutics.com
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/4e-therapeutics-127402 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.